HEADER TRANSFERASE 17-FEB-17 5UUT TITLE N-MYRISTOYLTRANSFERASE 1 (NMT) BOUND TO MYRISTOYL-COA COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLYCYLPEPTIDE N-TETRADECANOYLTRANSFERASE 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 29-416; COMPND 5 SYNONYM: MYRISTOYL-COA:PROTEIN N-MYRISTOYLTRANSFERASE 1,TYPE I N- COMPND 6 MYRISTOYLTRANSFERASE,PEPTIDE N-MYRISTOYLTRANSFERASE 1; COMPND 7 EC: 2.3.1.97; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NMT1, NMT; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS MYRISTOYLATION, MYRISTOYL-COA, CANCER, CO/POST-TRANSLATIONAL KEYWDS 2 MODIFICATION, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR O.GOODWIN,S.PEGAN REVDAT 3 06-MAR-24 5UUT 1 REMARK REVDAT 2 30-JAN-19 5UUT 1 JRNL REVDAT 1 17-JAN-18 5UUT 0 JRNL AUTH S.KIM,O.A.ALSAIDAN,O.GOODWIN,Q.LI,E.SULEJMANI,Z.HAN,A.BAI, JRNL AUTH 2 T.ALBERS,Z.BEHARRY,Y.G.ZHENG,J.S.NORRIS,Z.M.SZULC, JRNL AUTH 3 A.BIELAWSKA,I.LEBEDYEVA,S.D.PEGAN,H.CAI JRNL TITL BLOCKING MYRISTOYLATION OF SRC INHIBITS ITS KINASE ACTIVITY JRNL TITL 2 AND SUPPRESSES PROSTATE CANCER PROGRESSION. JRNL REF CANCER RES. V. 77 6950 2017 JRNL REFN ESSN 1538-7445 JRNL PMID 29038344 JRNL DOI 10.1158/0008-5472.CAN-17-0981 REMARK 2 REMARK 2 RESOLUTION. 2.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.10.1_2155: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.45 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 39222 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.173 REMARK 3 R VALUE (WORKING SET) : 0.171 REMARK 3 FREE R VALUE : 0.221 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.940 REMARK 3 FREE R VALUE TEST SET COUNT : 1937 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 38.4600 - 5.4220 0.99 2876 162 0.1699 0.1883 REMARK 3 2 5.4220 - 4.3055 1.00 2767 138 0.1323 0.1801 REMARK 3 3 4.3055 - 3.7618 1.00 2722 139 0.1409 0.1753 REMARK 3 4 3.7618 - 3.4181 1.00 2710 139 0.1620 0.1960 REMARK 3 5 3.4181 - 3.1732 1.00 2689 145 0.1774 0.2422 REMARK 3 6 3.1732 - 2.9862 1.00 2699 141 0.1912 0.2636 REMARK 3 7 2.9862 - 2.8367 1.00 2677 137 0.2023 0.2798 REMARK 3 8 2.8367 - 2.7132 1.00 2663 130 0.2114 0.2545 REMARK 3 9 2.7132 - 2.6088 1.00 2702 137 0.2075 0.2760 REMARK 3 10 2.6088 - 2.5188 1.00 2629 152 0.1938 0.2640 REMARK 3 11 2.5188 - 2.4401 1.00 2651 136 0.1981 0.2825 REMARK 3 12 2.4401 - 2.3703 1.00 2678 137 0.1942 0.2649 REMARK 3 13 2.3703 - 2.3079 0.99 2643 136 0.2010 0.3296 REMARK 3 14 2.3079 - 2.2516 0.83 2179 108 0.2033 0.2621 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.240 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.310 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 6560 REMARK 3 ANGLE : 1.010 8932 REMARK 3 CHIRALITY : 0.060 963 REMARK 3 PLANARITY : 0.008 1123 REMARK 3 DIHEDRAL : 16.268 3922 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5UUT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-FEB-17. REMARK 100 THE DEPOSITION ID IS D_1000226499. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-JUN-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX300-HS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 39222 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.250 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 4.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 22.0900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.41 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 22.5% PEG 4000, 5 MM NICL2, 100 MM REMARK 280 SODIUM CITRATE PH 4.5, AND 2.5% GLYCEROL, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 39.38900 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 88.79100 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 39.38900 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 88.79100 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 106 REMARK 465 PRO A 107 REMARK 465 HIS A 108 REMARK 465 MET A 109 REMARK 465 GLU A 110 REMARK 465 GLU A 111 REMARK 465 ALA A 112 REMARK 465 SER A 113 REMARK 465 LYS A 114 REMARK 465 ARG A 316 REMARK 465 ASN A 317 REMARK 465 MET A 408 REMARK 465 ASN A 409 REMARK 465 HIS A 410 REMARK 465 PRO A 411 REMARK 465 THR A 412 REMARK 465 HIS A 413 REMARK 465 LYS A 414 REMARK 465 GLY B 106 REMARK 465 PRO B 107 REMARK 465 HIS B 108 REMARK 465 MET B 109 REMARK 465 GLU B 110 REMARK 465 GLU B 111 REMARK 465 ALA B 112 REMARK 465 SER B 113 REMARK 465 LYS B 114 REMARK 465 ARG B 316 REMARK 465 ASN B 317 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU A 489 O HOH A 601 1.97 REMARK 500 O HOH B 616 O HOH B 741 2.00 REMARK 500 O HOH B 642 O HOH B 744 2.01 REMARK 500 O HOH A 641 O HOH A 657 2.02 REMARK 500 NE2 HIS A 135 O HOH A 602 2.02 REMARK 500 O HOH A 638 O HOH A 674 2.06 REMARK 500 OD1 ASP B 141 O HOH B 601 2.08 REMARK 500 O HOH A 658 O HOH A 770 2.10 REMARK 500 OE2 GLU B 244 O HOH B 602 2.11 REMARK 500 OE2 GLU A 489 O HOH A 603 2.11 REMARK 500 O GLU A 139 O HOH A 604 2.15 REMARK 500 O HOH B 716 O HOH B 724 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 308 CD GLU A 308 OE1 -0.080 REMARK 500 GLU A 308 CD GLU A 308 OE2 -0.074 REMARK 500 ARG B 295 NE ARG B 295 CZ -0.090 REMARK 500 ARG B 295 CZ ARG B 295 NH1 -0.087 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 185 CB - CG - OD2 ANGL. DEV. = -6.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 116 77.56 58.67 REMARK 500 TYR A 236 -119.43 52.33 REMARK 500 ASN A 302 79.03 -114.20 REMARK 500 ILE A 381 -65.06 -129.43 REMARK 500 PHE A 422 -86.52 -113.01 REMARK 500 THR A 427 -56.85 -121.62 REMARK 500 MET A 456 -131.21 44.26 REMARK 500 LYS A 466 32.04 70.75 REMARK 500 TYR B 236 -117.61 52.34 REMARK 500 ASN B 302 74.18 -113.30 REMARK 500 ILE B 381 -67.27 -132.31 REMARK 500 THR B 412 -64.80 -97.07 REMARK 500 PHE B 422 -83.31 -112.27 REMARK 500 THR B 427 -59.21 -123.43 REMARK 500 GLN B 428 -61.18 -99.59 REMARK 500 MET B 456 -136.03 48.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MYA A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CIT A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MYA B 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CIT B 502 DBREF 5UUT A 109 496 UNP P30419 NMT1_HUMAN 29 416 DBREF 5UUT B 109 496 UNP P30419 NMT1_HUMAN 29 416 SEQADV 5UUT GLY A 106 UNP P30419 EXPRESSION TAG SEQADV 5UUT PRO A 107 UNP P30419 EXPRESSION TAG SEQADV 5UUT HIS A 108 UNP P30419 EXPRESSION TAG SEQADV 5UUT GLY B 106 UNP P30419 EXPRESSION TAG SEQADV 5UUT PRO B 107 UNP P30419 EXPRESSION TAG SEQADV 5UUT HIS B 108 UNP P30419 EXPRESSION TAG SEQRES 1 A 391 GLY PRO HIS MET GLU GLU ALA SER LYS ARG SER TYR GLN SEQRES 2 A 391 PHE TRP ASP THR GLN PRO VAL PRO LYS LEU GLY GLU VAL SEQRES 3 A 391 VAL ASN THR HIS GLY PRO VAL GLU PRO ASP LYS ASP ASN SEQRES 4 A 391 ILE ARG GLN GLU PRO TYR THR LEU PRO GLN GLY PHE THR SEQRES 5 A 391 TRP ASP ALA LEU ASP LEU GLY ASP ARG GLY VAL LEU LYS SEQRES 6 A 391 GLU LEU TYR THR LEU LEU ASN GLU ASN TYR VAL GLU ASP SEQRES 7 A 391 ASP ASP ASN MET PHE ARG PHE ASP TYR SER PRO GLU PHE SEQRES 8 A 391 LEU LEU TRP ALA LEU ARG PRO PRO GLY TRP LEU PRO GLN SEQRES 9 A 391 TRP HIS CYS GLY VAL ARG VAL VAL SER SER ARG LYS LEU SEQRES 10 A 391 VAL GLY PHE ILE SER ALA ILE PRO ALA ASN ILE HIS ILE SEQRES 11 A 391 TYR ASP THR GLU LYS LYS MET VAL GLU ILE ASN PHE LEU SEQRES 12 A 391 CYS VAL HIS LYS LYS LEU ARG SER LYS ARG VAL ALA PRO SEQRES 13 A 391 VAL LEU ILE ARG GLU ILE THR ARG ARG VAL HIS LEU GLU SEQRES 14 A 391 GLY ILE PHE GLN ALA VAL TYR THR ALA GLY VAL VAL LEU SEQRES 15 A 391 PRO LYS PRO VAL GLY THR CYS ARG TYR TRP HIS ARG SER SEQRES 16 A 391 LEU ASN PRO ARG LYS LEU ILE GLU VAL LYS PHE SER HIS SEQRES 17 A 391 LEU SER ARG ASN MET THR MET GLN ARG THR MET LYS LEU SEQRES 18 A 391 TYR ARG LEU PRO GLU THR PRO LYS THR ALA GLY LEU ARG SEQRES 19 A 391 PRO MET GLU THR LYS ASP ILE PRO VAL VAL HIS GLN LEU SEQRES 20 A 391 LEU THR ARG TYR LEU LYS GLN PHE HIS LEU THR PRO VAL SEQRES 21 A 391 MET SER GLN GLU GLU VAL GLU HIS TRP PHE TYR PRO GLN SEQRES 22 A 391 GLU ASN ILE ILE ASP THR PHE VAL VAL GLU ASN ALA ASN SEQRES 23 A 391 GLY GLU VAL THR ASP PHE LEU SER PHE TYR THR LEU PRO SEQRES 24 A 391 SER THR ILE MET ASN HIS PRO THR HIS LYS SER LEU LYS SEQRES 25 A 391 ALA ALA TYR SER PHE TYR ASN VAL HIS THR GLN THR PRO SEQRES 26 A 391 LEU LEU ASP LEU MET SER ASP ALA LEU VAL LEU ALA LYS SEQRES 27 A 391 MET LYS GLY PHE ASP VAL PHE ASN ALA LEU ASP LEU MET SEQRES 28 A 391 GLU ASN LYS THR PHE LEU GLU LYS LEU LYS PHE GLY ILE SEQRES 29 A 391 GLY ASP GLY ASN LEU GLN TYR TYR LEU TYR ASN TRP LYS SEQRES 30 A 391 CYS PRO SER MET GLY ALA GLU LYS VAL GLY LEU VAL LEU SEQRES 31 A 391 GLN SEQRES 1 B 391 GLY PRO HIS MET GLU GLU ALA SER LYS ARG SER TYR GLN SEQRES 2 B 391 PHE TRP ASP THR GLN PRO VAL PRO LYS LEU GLY GLU VAL SEQRES 3 B 391 VAL ASN THR HIS GLY PRO VAL GLU PRO ASP LYS ASP ASN SEQRES 4 B 391 ILE ARG GLN GLU PRO TYR THR LEU PRO GLN GLY PHE THR SEQRES 5 B 391 TRP ASP ALA LEU ASP LEU GLY ASP ARG GLY VAL LEU LYS SEQRES 6 B 391 GLU LEU TYR THR LEU LEU ASN GLU ASN TYR VAL GLU ASP SEQRES 7 B 391 ASP ASP ASN MET PHE ARG PHE ASP TYR SER PRO GLU PHE SEQRES 8 B 391 LEU LEU TRP ALA LEU ARG PRO PRO GLY TRP LEU PRO GLN SEQRES 9 B 391 TRP HIS CYS GLY VAL ARG VAL VAL SER SER ARG LYS LEU SEQRES 10 B 391 VAL GLY PHE ILE SER ALA ILE PRO ALA ASN ILE HIS ILE SEQRES 11 B 391 TYR ASP THR GLU LYS LYS MET VAL GLU ILE ASN PHE LEU SEQRES 12 B 391 CYS VAL HIS LYS LYS LEU ARG SER LYS ARG VAL ALA PRO SEQRES 13 B 391 VAL LEU ILE ARG GLU ILE THR ARG ARG VAL HIS LEU GLU SEQRES 14 B 391 GLY ILE PHE GLN ALA VAL TYR THR ALA GLY VAL VAL LEU SEQRES 15 B 391 PRO LYS PRO VAL GLY THR CYS ARG TYR TRP HIS ARG SER SEQRES 16 B 391 LEU ASN PRO ARG LYS LEU ILE GLU VAL LYS PHE SER HIS SEQRES 17 B 391 LEU SER ARG ASN MET THR MET GLN ARG THR MET LYS LEU SEQRES 18 B 391 TYR ARG LEU PRO GLU THR PRO LYS THR ALA GLY LEU ARG SEQRES 19 B 391 PRO MET GLU THR LYS ASP ILE PRO VAL VAL HIS GLN LEU SEQRES 20 B 391 LEU THR ARG TYR LEU LYS GLN PHE HIS LEU THR PRO VAL SEQRES 21 B 391 MET SER GLN GLU GLU VAL GLU HIS TRP PHE TYR PRO GLN SEQRES 22 B 391 GLU ASN ILE ILE ASP THR PHE VAL VAL GLU ASN ALA ASN SEQRES 23 B 391 GLY GLU VAL THR ASP PHE LEU SER PHE TYR THR LEU PRO SEQRES 24 B 391 SER THR ILE MET ASN HIS PRO THR HIS LYS SER LEU LYS SEQRES 25 B 391 ALA ALA TYR SER PHE TYR ASN VAL HIS THR GLN THR PRO SEQRES 26 B 391 LEU LEU ASP LEU MET SER ASP ALA LEU VAL LEU ALA LYS SEQRES 27 B 391 MET LYS GLY PHE ASP VAL PHE ASN ALA LEU ASP LEU MET SEQRES 28 B 391 GLU ASN LYS THR PHE LEU GLU LYS LEU LYS PHE GLY ILE SEQRES 29 B 391 GLY ASP GLY ASN LEU GLN TYR TYR LEU TYR ASN TRP LYS SEQRES 30 B 391 CYS PRO SER MET GLY ALA GLU LYS VAL GLY LEU VAL LEU SEQRES 31 B 391 GLN HET MYA A 501 63 HET CIT A 502 13 HET MYA B 501 63 HET CIT B 502 13 HETNAM MYA TETRADECANOYL-COA HETNAM CIT CITRIC ACID HETSYN MYA MYRISTOYL-COA FORMUL 3 MYA 2(C35 H62 N7 O17 P3 S) FORMUL 4 CIT 2(C6 H8 O7) FORMUL 7 HOH *340(H2 O) HELIX 1 AA1 PHE A 119 GLN A 123 5 5 HELIX 2 AA2 ASP A 165 TYR A 180 1 16 HELIX 3 AA3 SER A 193 ARG A 202 1 10 HELIX 4 AA4 LEU A 207 GLN A 209 5 3 HELIX 5 AA5 LYS A 252 ARG A 255 5 4 HELIX 6 AA6 VAL A 259 LEU A 273 1 15 HELIX 7 AA7 ASN A 302 VAL A 309 1 8 HELIX 8 AA8 THR A 319 ARG A 328 1 10 HELIX 9 AA9 GLU A 342 LYS A 344 5 3 HELIX 10 AB1 ASP A 345 LEU A 357 1 13 HELIX 11 AB2 LYS A 358 PHE A 360 5 3 HELIX 12 AB3 SER A 367 TYR A 376 1 10 HELIX 13 AB4 PRO A 430 LYS A 445 1 16 HELIX 14 AB5 GLU A 457 PHE A 461 5 5 HELIX 15 AB6 GLY A 487 VAL A 491 5 5 HELIX 16 AB7 PHE B 119 GLN B 123 5 5 HELIX 17 AB8 ASP B 165 TYR B 180 1 16 HELIX 18 AB9 SER B 193 ARG B 202 1 10 HELIX 19 AC1 LEU B 207 GLN B 209 5 3 HELIX 20 AC2 LYS B 252 ARG B 255 5 4 HELIX 21 AC3 ARG B 258 LEU B 273 1 16 HELIX 22 AC4 ASN B 302 VAL B 309 1 8 HELIX 23 AC5 THR B 319 TYR B 327 1 9 HELIX 24 AC6 GLU B 342 LYS B 344 5 3 HELIX 25 AC7 ASP B 345 LYS B 358 1 14 HELIX 26 AC8 SER B 367 TYR B 376 1 10 HELIX 27 AC9 PRO B 430 LYS B 445 1 16 HELIX 28 AD1 GLU B 457 GLU B 463 1 7 HELIX 29 AD2 GLY B 487 VAL B 491 5 5 SHEET 1 AA112 PHE A 156 ALA A 160 0 SHEET 2 AA112 HIS A 211 VAL A 216 -1 O ARG A 215 N THR A 157 SHEET 3 AA112 LEU A 222 ILE A 235 -1 O ILE A 226 N CYS A 212 SHEET 4 AA112 THR A 238 VAL A 250 -1 O MET A 242 N ALA A 231 SHEET 5 AA112 ALA A 279 ALA A 283 1 O VAL A 280 N VAL A 243 SHEET 6 AA112 GLY A 468 TYR A 479 -1 O GLN A 475 N ALA A 283 SHEET 7 AA112 GLY A 292 SER A 300 -1 N TYR A 296 O GLY A 470 SHEET 8 AA112 VAL A 449 LEU A 453 -1 O PHE A 450 N ARG A 299 SHEET 9 AA112 ALA A 418 SER A 421 1 N SER A 421 O ASN A 451 SHEET 10 AA112 VAL A 394 THR A 402 -1 N TYR A 401 O TYR A 420 SHEET 11 AA112 ILE A 382 GLU A 388 -1 N VAL A 387 O ASP A 396 SHEET 12 AA112 LEU A 338 PRO A 340 -1 N ARG A 339 O VAL A 386 SHEET 1 AA2 4 PHE A 156 ALA A 160 0 SHEET 2 AA2 4 HIS A 211 VAL A 216 -1 O ARG A 215 N THR A 157 SHEET 3 AA2 4 LEU A 222 ILE A 235 -1 O ILE A 226 N CYS A 212 SHEET 4 AA2 4 LEU A 362 VAL A 365 -1 O THR A 363 N HIS A 234 SHEET 1 AA3 2 ARG A 189 PHE A 190 0 SHEET 2 AA3 2 SER A 405 THR A 406 -1 O THR A 406 N ARG A 189 SHEET 1 AA412 PHE B 156 ALA B 160 0 SHEET 2 AA412 HIS B 211 VAL B 216 -1 O ARG B 215 N THR B 157 SHEET 3 AA412 LEU B 222 ILE B 235 -1 O GLY B 224 N VAL B 214 SHEET 4 AA412 THR B 238 VAL B 250 -1 O MET B 242 N ALA B 231 SHEET 5 AA412 ALA B 279 ALA B 283 1 O VAL B 280 N VAL B 243 SHEET 6 AA412 GLY B 468 TYR B 479 -1 O TYR B 479 N ALA B 279 SHEET 7 AA412 GLY B 292 SER B 300 -1 N CYS B 294 O LEU B 474 SHEET 8 AA412 VAL B 449 LEU B 453 -1 O ALA B 452 N TRP B 297 SHEET 9 AA412 ALA B 418 SER B 421 1 N ALA B 419 O ASN B 451 SHEET 10 AA412 VAL B 394 THR B 402 -1 N TYR B 401 O TYR B 420 SHEET 11 AA412 ILE B 382 GLU B 388 -1 N PHE B 385 O LEU B 398 SHEET 12 AA412 LEU B 338 PRO B 340 -1 N ARG B 339 O VAL B 386 SHEET 1 AA5 4 PHE B 156 ALA B 160 0 SHEET 2 AA5 4 HIS B 211 VAL B 216 -1 O ARG B 215 N THR B 157 SHEET 3 AA5 4 LEU B 222 ILE B 235 -1 O GLY B 224 N VAL B 214 SHEET 4 AA5 4 LEU B 362 VAL B 365 -1 O THR B 363 N HIS B 234 SHEET 1 AA6 3 PHE B 188 PHE B 190 0 SHEET 2 AA6 3 SER B 405 ILE B 407 -1 O THR B 406 N ARG B 189 SHEET 3 AA6 3 SER B 415 LEU B 416 -1 O LEU B 416 N SER B 405 CISPEP 1 PRO A 288 LYS A 289 0 -19.08 CISPEP 2 PRO A 288 LYS A 289 0 -19.30 CISPEP 3 PRO B 288 LYS B 289 0 -19.85 SITE 1 AC1 34 TYR A 117 GLN A 118 PHE A 119 TRP A 120 SITE 2 AC1 34 ASN A 179 TYR A 180 VAL A 181 ILE A 245 SITE 3 AC1 34 ASN A 246 PHE A 247 LEU A 248 CYS A 249 SITE 4 AC1 34 VAL A 250 ARG A 255 SER A 256 LYS A 257 SITE 5 AC1 34 ARG A 258 VAL A 259 ALA A 260 PRO A 261 SITE 6 AC1 34 THR A 268 VAL A 271 ILE A 276 PHE A 277 SITE 7 AC1 34 ALA A 279 TYR A 281 THR A 282 LEU A 287 SITE 8 AC1 34 TYR A 479 HOH A 686 HOH A 688 HOH A 705 SITE 9 AC1 34 HOH A 712 HOH A 725 SITE 1 AC2 11 THR A 122 GLN A 123 GLU A 139 LYS A 142 SITE 2 AC2 11 ARG A 265 ASN A 389 ALA A 390 HOH A 647 SITE 3 AC2 11 HOH A 653 HOH A 669 HOH A 736 SITE 1 AC3 36 TYR B 117 GLN B 118 PHE B 119 TRP B 120 SITE 2 AC3 36 ASN B 179 TYR B 180 VAL B 181 ILE B 245 SITE 3 AC3 36 ASN B 246 PHE B 247 LEU B 248 CYS B 249 SITE 4 AC3 36 VAL B 250 ARG B 255 SER B 256 LYS B 257 SITE 5 AC3 36 ARG B 258 VAL B 259 ALA B 260 PRO B 261 SITE 6 AC3 36 ILE B 264 THR B 268 VAL B 271 HIS B 272 SITE 7 AC3 36 ILE B 276 PHE B 277 ALA B 279 TYR B 281 SITE 8 AC3 36 THR B 282 LEU B 287 TYR B 479 HOH B 646 SITE 9 AC3 36 HOH B 651 HOH B 700 HOH B 717 HOH B 719 SITE 1 AC4 10 THR B 122 GLN B 123 GLU B 139 LYS B 142 SITE 2 AC4 10 ARG B 265 ASN B 389 ALA B 390 HOH B 612 SITE 3 AC4 10 HOH B 683 HOH B 698 CRYST1 78.778 177.582 58.566 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012694 0.000000 0.000000 0.00000 SCALE2 0.000000 0.005631 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017075 0.00000